Revenue
2024
2025
DataMeds AI, Inc. (MEDS)
Price—Loading quote
Net income
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $23.3M | $18.1M | — |
| Gross profit | −$6.4M | $1.8M | — |
| Operating expenses | $87.3M | $7.9M | $2.9M |
| Operating income | −$93.7M | −$6.1M | −$2.9M |
| EBITDAderived | −$90.5M | −$5.0M | — |
| Net income | −$101.3M | −$6.9M | −$2.9M |
| Basic EPSper diluted share | -$1.43 | -$0.15 | -$0.06 |
| Diluted EPSper diluted share | -$1.43 | -$0.15 | -$0.06 |